Moderna Stock Is Spiking Because an Omicron Covid Vaccine Could Be Ready in Early 2022
This transcript is for your personal, non-commercial usage only. To bid presentation-ready copies for organisation to your colleagues, clients oregon customers sojourn http://www.djreprints.com.
https://www.barrons.com/articles/moderna-mrna-stock-spikes-vaccine-omicron-variant-51638180681
Updated Nov. 29, 2021 6:24 americium ET / Original Nov. 29, 2021 5:12 americium ET
- Order Reprints
- Print Article
Moderna banal was rising sharply successful premarket trading Monday aft the vaccine shaper said a reformulated vaccine to tackle the Omicron covid variant could beryllium acceptable successful aboriginal 2022.
Moderna (ticker: MRNA) roseate much than 9% to $359.80 successful premarket trading Monday. The banal gained 20.6% connected Friday aft Moderna said it was moving to rapidly beforehand an Omicron-specific booster candidate, targeting 60 to 90 days for objective investigating to begin.
“We...
What's Your Reaction?
